3-Hydroxy-2'-methoxy-6-methylflavone: a potent anxiolytic with a unique selectivity profile at GABA(A) receptor subtypes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemical Pharmacology

• Publication date

  2011-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2011.09.002PMID 21924247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2′‐Methoxy‐6‐methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABAA receptors

  2012cited by this paper
• GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.

  2011cited by this paper
• Retrochalcone derivatives are positive allosteric modulators at synaptic and extrasynaptic GABAA receptors in vitro

  2011cited by this paper
• Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors.

  2010cited by this paper
• GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone.

  2010cited by this paper
• Limiting Activity at β1-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia

  2010cited by this paper
• The Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice

  2009cited by this paper
• Novel, Potent, and Selective GABAC Antagonists Inhibit Myopia Development and Facilitate Learning and Memory

  2008cited by this paper
• International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update

  2008cited by this paper
• Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.

  2008influential reference
• The use of the elevated plus maze as an assay of anxiety-related behavior in rodents

  2007cited by this paper
• The novel anxiolytic ELB139 displays selectivity to recombinant GABA(A) receptors different from diazepam.

  2007cited by this paper
• Both α2 and α3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm

  2006cited by this paper
• Low dose acute alcohol effects on GABA A receptor subtypes.

  2006cited by this paper
• Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.

  2006cited by this paper
• TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

  2006cited by this paper
• GABA-A receptors: a viable target for novel anxiolytics?

  2006cited by this paper
• Pharmacological Characterization of Agonists at δ-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of γ2

  2006cited by this paper
• Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain.

  2005cited by this paper
• Novel Cyclic γ-Hydroxybutyrate (GHB) Analogs with High Affinity and Stereoselectivity of Binding to GHB Sites in Rat Brain

  2005cited by this paper
• GABA(A) receptor channel pharmacology.

  2005cited by this paper
• Determinants of amentoflavone interaction at the GABA(A) receptor.

  2005cited by this paper
• Neurosteroids: endogenous regulators of the GABAA receptor

  2005cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes.

  2005cited by this paper
• The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics

  2005cited by this paper
• Neuroactive flavonoids interacting with GABAA receptor complex.

  2005cited by this paper
• Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.

  2005cited by this paper
• 6-Methylflavanone, a more efficacious positive allosteric modulator of γ-aminobutyric acid (GABA) action at human recombinant α2β2γ2L than at α1β2γ2L and α1β2 GABAA receptors expressed in Xenopus oocytes

  2005cited by this paper
• Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity

  2005cited by this paper
• Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors.

  2004cited by this paper
• Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects

  2004cited by this paper
• Analysis of the Set of GABAA Receptor Genes in the Human Genome*

  2004cited by this paper
• Flumazenil-independent positive modulation of γ-aminobutyric acid action by 6-methylflavone at human recombinant α1β2γ2L and α1β2 GABAA receptors

  2004cited by this paper
• Multiple actions of propofol on alphabetagamma and alphabetadelta GABAA receptors.

  2004cited by this paper
• Compounds Exhibiting Selective Efficacy for Different β Subunits of Human Recombinant γ-Aminobutyric AcidA Receptors

  2004cited by this paper
• Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptors.

  2004cited by this paper
• The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood–brain barrier and exhibits anticonvulsive effects

  2004cited by this paper
• Multiple Actions of Propofol on αβγ and αβδ GABAA Receptors

  2004cited by this paper
• Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system.

  2004cited by this paper
• Modifying quinolone antibiotics yields new anxiolytics

  2004cited by this paper
• The mouse light/dark box test.

  2003cited by this paper
• Deletion of the α1 or β2 Subunit of GABAAReceptors Reduces Actions of Alcohol and Other Drugs

  2003cited by this paper
• Enhanced Neurosteroid Potentiation of Ternary GABAAReceptors Containing the δ Subunit

  2002cited by this paper
• Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.

  2002cited by this paper
• Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit.

  2002cited by this paper
• Trace fear conditioning involves hippocampal α5 GABAA receptors

  2002cited by this paper
• Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi.

  2002cited by this paper
• Commentary on: “Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse.” Psychopharmacologia (1968) 13:222257

  2002cited by this paper
• A new benzodiazepine pharmacology.

  2002cited by this paper
• Molecular targets for the myorelaxant action of diazepam.

  2001cited by this paper
• Which GABA ,-receptor subtypes really occur in the brain ?

  2001cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• Behavioral characterisation of the flavonoids apigenin and chrysin.

  2000cited by this paper
• Molecular and neuronal substrate for the selective attenuation of anxiety.

  2000cited by this paper
• Advances in flavonoid research since 1992.

  2000cited by this paper
• erratum: Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

  2000cited by this paper
• Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

  1999cited by this paper
• Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

  1999cited by this paper
• Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

  1999cited by this paper
• Pharmacological studies on synthetic flavonoids: comparison with diazepam.

  1999cited by this paper
• International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

  1998cited by this paper
• GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands.

  1997cited by this paper
• The rapidly expanding range of neuronal benzodiazepine receptor ligands.

  1993cited by this paper
• GABAA receptors are differentially sensitive to zinc: dependence on subunit composition

  1991cited by this paper
• High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro.

  1988cited by this paper
• Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

  1986cited by this paper
• The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard

  1985cited by this paper
• Exploratory behavior models of anxiety in mice.

  1985cited by this paper
• Effects of THIP on chronic anxiety

  1983cited by this paper
• Benzodiazepine receptor ligands with positive and negative efficacy.

  1983cited by this paper
• Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.

  1974cited by this paper
• Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

  1968cited by this paper
• A new synthesis of flavonols

  1955cited by this paper

• Methyl Derivatives of Flavone as Potential Anti-Inflammatory Compounds

  2025cites this paper
• Flavonoids as Anxiolytics in Animal Tests: Systematic Review, Meta‐Analysis, and Bibliometrical Analysis

  2025cites this paper
• Attenuation of Streptozotocin-Induced Diabetic Neuropathic Allodynia by Flavone Derivative Through Modulation of GABA-ergic Mechanisms and Endogenous Biomarkers

  2024cites this paper
• Flavonoids as anxiolytics in animal tests: Bibliometry and meta-analysis of the effects of flavonoids on anxiety-like behavior in animal tests

  2024cites this paper
• The Binding of Alpinia galanga Oil and Its Nanoemulsion to Mammal GABAA Receptors Using Rat Cortical Membranes and an In Silico Modeling Platform

  2022cites this paper
• Phenolics as GABAA Receptor Ligands: An Updated Review

  2022cites this paper
• Binding effects of Alpinia galanga oil and its nanoemulsion 1 to GABAA receptors in rat cortical membranes

  2021cites this paper
• Stigmasterol can be new steroidal drug for neurological disorders: Evidence of the GABAergic mechanism via receptor modulation.

  2021cites this paper
• Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABAA receptors

  2020cites this paper
• Anxiolytic-like activity of 5-methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences.

  2020cites this paper
• Flavonoid compounds isolated from Tibetan herbs, binding to GABAA receptor with anxiolytic property.

  2020cites this paper
• Involvement of selective GABA-A receptor subtypes in amelioration of cisplatin-induced neuropathic pain by 2’-chloro-6-methyl flavone (2’-Cl-6MF)

  2020cites this paper
• GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators.

  2019cites this paper
• Development of a Robust Mammalian Cell‐based Assay for Studying Recombinant α4β1/3δ GABAA Receptor Subtypes

  2017cites this paper
• Antidepressant, anticonvulsant and antinociceptive effects of 3′-methoxy-6-methylflavone and 3′-hydroxy-6-methylflavone may involve GABAergic mechanisms

  2017cites this paper
• Flavonoids in Transgenic Alzheimer's Disease Mouse Models

  2017cites this paper
• Characterization of 6‐methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach

  2017cites this paper
• GABA-A Receptor Modulation and Anticonvulsant, Anxiolytic, and Antidepressant Activities of Constituents from Artemisia indica Linn

  2016cites this paper
• Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface

  2016cites this paper
• A pharmacological characterization of GABA, THIP and DS2 at binary α4β3 and β3δ receptors: GABA activates β3δ receptors via the β3(+)δ(-) interface.

  2016cites this paper
• Hepatoprotective activity of viscosine is mediated by attenuation of hepatic macrophages and iNOS expression in CCl4-intoxicated rats.

  2016cites this paper
• Lipid Colloidal Systems: A Strategy to Deliver Natural Bioactive Compounds

  2016cites this paper
• Pharmacological characterisation of murine α4β1δ GABAA receptors expressed in Xenopus oocytes

  2015cites this paper
• Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents from Rosmarinus Officinalis.

  2015cites this paper
• Interactions of flavonoids with ionotropic GABA receptors.

  2015cites this paper
• GABA(A) receptor modulation and neuropharmacological activities of viscosine isolated from Dodonaea viscosa (Linn).

  2015influential citation
• The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.

  2015cites this paper
• Analysis of γ-Aminobutyric Acid (GABA) Type A Receptor Subtypes Using Isosteric and Allosteric Ligands

  2014cites this paper
• Modulation of Ionotropic GABA Receptors by 6-Methoxyflavanone and 6-Methoxyflavone

  2014cites this paper
• Ethnomedicine-based discovery and characterization of plant-derived GABAΑ receptor modulators with new scaffolds

  2014cites this paper
• Montanoa frutescens and Montanoa grandiflora Extracts Reduce Anxiety-Like Behavior during the Metestrus-Diestrus Phase of the Ovarian Cycle in Wistar Rats

  2014cites this paper
• HPLC-based activity profiling for GABAA receptor modulators in Adenocarpus cincinnatus.

  2014cites this paper
• Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin.

  2014cites this paper
• Quercetin antagonism of GABAAρ₁ receptors is prevented by ascorbic acid through a redox-independent mechanism.

  2013cites this paper
• Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.

  2013cites this paper
• Potency of GABA at human recombinant GABAA receptors expressed in Xenopus oocytes: a mini review

  2013cites this paper
• Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors.

  2012cites this paper
• Flavonoids as GABAA receptor ligands: the whole story?

  2012cites this paper
• Low nanomolar GABA effects at extrasynaptic a 4 b 1 / b 3 d GABAA receptor subtypes indicate a different binding mode for GABA at these receptors

  2012cites this paper
• Anxiolytic-like Effects of the Methanol Extract of Sophorae Fructus

  2012cites this paper
• α4βδ GABAA receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)

  2012cites this paper
• The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: involvement of GABAA receptor.

  2012cites this paper